Bill Hawkins

Devices & Diagnostics

Former Medtronic CEO to chair initiative to advance regulatory science

LifeScience Alley, which represents the medical device industry in Minnesota, announced Wednesday that former Medtronic CEO Bill Hawkins will be the inaugural chairman of a new public-private partnership to advance regulatory science. Regulatory science is a set of tools and methods for evaluating the safety, effectiveness, quality and performance of medical devices. The three entities […]

Devices & Diagnostics

Medtronic to fund bio-pharm clinical trial for heart failure

Medtronic Inc. (NYSE:MDT) will fund a clinical trial for Nile Therapeutics Inc. (NSDQ:NLTX) behind a peptide treatment for heart failure. The San Mateo, Calif. biopharmaceutical company said Medtronic will also provide expertise on building a drug-device combination as Nile completes a Phase I trial to "assess the pharmacokinetics and phamacodynamics of cenderitide delivered through Medtronic diabetes pump technology," according to a prepared release.

Devices & Diagnostics

Hawkins exit may show Medtronic’s need for bold leader/big deals

When Medtronic Inc. (NYSE:MDT) CEO Art Collins retired in 2007, there were at least two top candidates vying to replace him. One was Michael DeMane, the brash president of Medtronic's spine business whose aggressive pursuit of growth invited legal and regulatory scrutiny. The other was chief operating officer Bill Hawkins, a steady, stabilizing presence within Medtronic's senior leadership team.